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ARTICLE INFO ABSTRACT
Coronavirus disease is caused by severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) and to date, no novel treatment so far is available to cure it. Therefore, it 
is an urgent need to develop an effective treatment for the patients who are suffering 
from it. Naturally, when SARS-CoV-2 infection transpired, the nervous system of the body 
of the patient responds to it immediately by activating the immune cells that further 
triggered inflammation to counter it. In this fight, the cytokine storms originated in the 
host cells and it becomes life-threatening and finally, in absence of treatment, it eventually 
results in death. Therefore, the dysregulation of inflammatory immune responses, 
by any mean can improve the health of the patients. It was evident that most patients 
who were suffering from severe SARS-CoV-2, exhibit a high level of pro-inflammatory 
cytokines, including interferon (IFN)-α, and interleukin (IL)-1β. In these circumstances, 
an immunotherapeutic strategy will be effective for the suppression of cytokine storms 
and will prevent any respiratory failure in the patients.
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Introduction 
The pathology of cytokine storm is a very complex phenomenon 
in which a patient’s body produces high immune defense to counter 
external stimuli excessively. The speed of spreading of SARS-CoV-2 
infection is too high and therefore, the mortality rate is also high. 
Understanding the route of SARS-CoV-2 infection can provide 
deeper insight into outbreak, disease prognosis, and its involvement 
in the failure of multiple organs including acute respiratory distress 
syndrome, heart, renal, and liver. All the aforesaid symptoms are 
life-threatening [1]. The fight between SARS-CoV-2 and immune 
cells initiated a hyper-inflammatory response in the body that 
is identified by the pathological cytokine levels. These states 
are defined as cytokine storm syndrome and observed critical 
conditions marked the disease severity. It was evident from the 
observation that ongoing research on SARS-CoV-2 infection expose 
the causes responsible for the initiation of severe and deteriorated 
conditions of lungs which are inter-related to the emergence of 
cytokine storm in patient’s bodies. Here, the authors underlined the 
 
importance of elucidation of pathogenesis concerned with SARS-
CoV-2 infection, cytokine storm, and interrelated signaling.
These investigations will propose better treatment strategies 
for curing SARS-CoV-2 and controlling the induced inflammatory 
storm. These implemented strategies can suggest better medication 
guidelines for clinical treatment. The existence of a systemic hyper-
inflammation confirmed the acute respiratory distress syndrome 
and finally, these pathological conditions forced a failure in the 
functioning of many multiple organs [2]. Cytokine storm is the final 
state that refers to determining the clinical conditions caused by 
excessive immune reactions and underlined as one of the major 
causes occurred just because of SARS-CoV-2 infection. Therefore, 
it identifies a need for better elucidation of the pathogenesis of 
cytokine storm that has not yet been illuminated [3].
As cytokine storm initiated by SARS-CoV-2 infection, it is also 
responsible for the origin of various other features of cytokines, 
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such as IL-6 and IL-10 [4]. Many clinical trials and evidence have 
proved that the anti-inflammatory therapy is an effective strategy 
for a better treatment of SARS-CoV-2 infection. Recently, several 
remedies are used to treat the cytokine storm labelling it as 
cytokine-targeted therapies [5]. Varied research efforts are being 
continued to search a novel an anti-inflammatory treatment that 
can be useful in the prevention of SARS-CoV-2 infection. Here, the 
authors provide an overview on cytokine storm and discuss the 
current approach available for the treatment. They explore various 
other challenges that existed in cellular components responsible 
and that initiated the immune response, while dealing with a 
cytokine storm as well as other biological functions. In the end, 
the authors again conferred the few potential therapies that were 
applied to neutralise the cytokine storm.
However, high concentrations of pro-inflammatory cytokines 
are not the sole reason for the existence of the cytokine, but also 
there are many other processes that are not yet discovered, and 
that is why no complete scientific illustration of a cytokine storm 
possibly exist (Figure 1). Furthermore, there is a need to develop a 
blueprint of molecular mechanism underlying the cytokine storm 
that initiates the pathogenesis of SARS-CoV-2 infection [6]. The 
main cause behind these concepts is to develop more accurate 
therapeutic strategies that can be applied to prevent a cytokine 
storm or suppress it at the time of its origin. The aim of author for 
this short communication, is to define the concept of a cytokine 
storm, as well its inter-related signaling pathways, concerning 
biological consequences, and to discover the causes of cytokine 
overproduction. The authors also tried to explore some other 
features related to its genomics and tried to reveal more scientific 
inputs about the kinetics of cytokine and provided more details 
about the cytokine signaling as well as causes responsible for 
overlapping of cytokine signaling.
Figure 1: Schematic representation of cytokine storm. “Adapted and created with permission from [biorender.com] and ac-
knowledged.
Background
At the time of coronavirus attack, over-activation of the immune 
system transpired, such stages are defined as storm in medical term. 
A better understanding in the phenomenon of these kind of storms 
helps to recognise them as cytokine storm. The knowledge of the 
signaling routes of the storm, and pathogenesis of coronavirus 
will boost the possibilities to design a successful strategy for 
managing and planning for developing various treatment strategies 
[7]. Pathogens (virus or bacteria) must face a strong response of 
defense from the immune system of the host, during their outbreak 
and the white blood cells initiate the pinpoint against the pathogens 
to destroy them. When any pathogen attacked, the immune cells of 
the host identify it, trigger inflammation and in the meantime, they 
recruit more immune cells to counter it [8]. Meanwhile, the immune 
cells release cytokines, and signaling molecules to establish a better 
communication. Finally, cytokines triggered localized inflammation 
to destroy the aforesaid pathogens. The immune system keeps 
producing cytokines, as soon as it is over flooded, that is the sign of 
the emergence of a cytokine storm.
Later on, the excess inflammation damage multiple organs. 
Sometimes, an excess amount of cytokine hinders blood supply 
that affects the resource of oxygen and nutrients supply that is 
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transported to the various organs (heart, lungs, and brain). In 
many cases, a cytokine storm initiates acute respiratory distress 
syndrome, as a result, the lungs lose their natural functioning, and 
a hindrance in the supply of oxygen occurs (Figure 2) [9]. In these 
conditions, sometimes macrophages and white blood cells reach 
the lungs in a large concentration to kill the infection. It is a fatal 
situation for a patient.  These white blood cells initiate extensive 
inflammation to counter the pathogens, but sometimes it backfires, 
and respiratory failure transpires immediately [10].
Figure 2: Schematic representation of effects of SARS-CoV-2 on respiration. “Adapted and created with permission from [bi-
orender.com] and acknowledged.
Therefore, special type of remedies are required to calm the 
cytokine storm, and that are defiantly effective, or, other strategies 
that can reduce the activation path of immune cells or interference 
with the route of cytokine production will be helpful. The objective 
to discuss these strategies is just to propose a remedy that can block 
the specific signaling pathways by any means and will be fruitful 
to achieve the goal.  All the above-mentioned approaches can be 
risky because an immunosuppressive intervention, can further 
initiate the decline in the ratio of important immune cells during 
SARS-CoV-2 infection. But a remarkable acceleration of clinical 
trials can address such issues originated at the time of cytokine 
storm. Simultaneously, there presents an immediate need to search 
specific strategies to deal with it in most effective scientific manner, 
because it is a complex physiological and cellular response.  There 
are several other hopes that can be successful in developing more 
effective remedies for a better treatment of cytokine storm.
Discussion
To have an objective to develop a treatment and planned 
management schemes to prevent the pathogenesis of SARS-CoV-2 
infection will be an effective idea, but it can be achieved only if, there 
is a proper understanding of cytokine storms. These strategies can 
be also useful in the prevention of signaling pathways and in the 
discovery of hidden aspects of it. Because all these phenomena are 
interlinked with each other and responsible for the production of 
proinflammatory cytokines, so there emerges an urgent need to 
investigate it further. Authors underlined the causes that initiate 
deterioration in the health of affected patients. It was observed that 
they are directly linked with dysregulation and excessive release of 
cytokines.  The pathology of infectious disease, as well as the role 
of cytokine storm, conferred it and how the patients can mount 
immune responses to deal with the infection originated by SARS-
CoV-2, is an area that must be investigated [11].
Overall, how immunomodulatory therapies can improve 
clinical outcomes during severe acute infection, is a topic for further 
discussion. It was reported earlier that the concentration of pro-
inflammatory cytokines, interleukin (IL)-6, lead to the exhaustion of 
lymphocytes that are found in high amounts in severely ill patients 
[12]. Therefore, it was assumed that exploring any possibilities that 
can explore the mechanisms underlying of host immune responses, 
will be a pathfinder strategy and it must be discovered to treat the 
pathogenesis of SARS-CoV-2 infection. Any diagnostic tool that can 
detect antibodies, will also be helpful for sensitive and accurate 
detection. Recently, it was observed that IL-6 inhibitor displayed 
potential as an effective remedy, and it is also a safer one. Besides, 
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other remedies including antimalarial agents, corticosteroids, 
checkpoint inhibition, and intravenous immunoglobulin are useful 
for counting the cytokine storm [13].
The delivery of immunomodulatory therapies can be guided 
using a biosensor to enhance the impact of anti-inflammatory 
treatments. Here, an investigation based on bioinformatics theme 
was suggested for the elucidation of immune responses initiated 
and triggered by SARS-CoV-2 infection. These sites are located 
in primary human lung epithelial and later on transformed into 
human lung alveolar. Serious scientific intervention is required to 
explore the mechanisms behind these several complications that 
causes serious complications during SARS-CoV-2 infection [14]. 
These events further develop a specific cytokine storm which 
proceeds in the recruitment of an excessive neutrophil, initiate 
thrombosis, and initiate damages. The pathway of SARS-CoV-2 
infection has different clinical features, biological alterations, and 
various other mediators of pathophysiology. In brief, these varieties 
of infection enter into respiratory epithelial cells and pulmonary 
type-II pneumonitis. Then, these pathogens initiate the production 
of inflammatory cytokines that is associated with IFN-λ–dependent 
epithelial defense.
Signaling Pathways: Cytokine Storm
The initiation of SARS-CoV-2 infection has occurred due to acute 
respiratory distress syndrome, which in high severity, depends on a 
cytokine storm [15]. The interleukin-6 (IL-6) amplifier is one of the 
components of cytokine storm and perform as a hyper-activation 
machinery during the regulation of nuclear factor kappa B (NF-κB) 
pathway. The stimulation of these changes proceeds via activation 
of IL-6-signal transducer. All these variations transpired like a 
chain reaction (Figure 3). These intermediators further initiate 
transcription 3 (STAT3) and NF-κB signaling in epithelial and 
endothelial cells. By targeting IL-6, new therapeutic strategies can 
be planned to stop the inflammation. 
Figure 3: Schematic representation of signaling of cytokine storm. “Adapted and created with permission from [biorender.
com] and acknowledged.
By elucidating the signaling pathways of cytokine storm, a new 
approach can be developed to review the pathogenic mechanism for 
searching a potential therapeutic target [16]. The pro-inflammatory 
cytokines such as interleukin (IL)−1B, IL-6, IL-8, IL-17, interferon-
γ-inducible protein (IP10), and granulocyte-macrophage colony-
stimulating factor must be investigated to have a better look on 
signaling pathways of cytokine release and its conversion into a 
storm [17].
Conclusion
Urgent investigation about the physiology of cytokine storm is 
required for the development preventive and therapeutic drugs. 
Besides, the immunomodulatory therapies can be a better option 
for it. Strong immune responses can build a better defence against 
the viral infection and inflammatory innate response. Overall, it 
is a well-known knowledge that massive cytokine and chemokine 
Copyright@ Rajiv Kumar | Biomed J Sci & Tech Res | BJSTR. MS.ID.005715.
Volume 35- Issue 3 DOI: 10.26717/BJSTR.2021.35.005715
27758
dysregulated the host immune defense that are responsible for the 
formation of a cytokine storm. The option to counter the progression 
of cytokine storm can only be possible if a proper understanding of 
immune signaling pathways of the triggered situations when SARS-
CoV-2 infection attack is available.
These investigations will further reveal the mechanism of 
molecular cascades participating in various biological processes 
that intervene with the viral infections and can underline the 
concerned active molecular events that are responsible for 
triggering it. A deeper understanding of the mechanism when 
the immune system initiate dysregulation might be helpful, in the 
clinical management of SARS-CoV-2 infection and in the designing 
of prevention strategies. Even though various studies have been 
reported, once infected by SARS-CoV-2, patients must be considered 
vulnerable for reappearance of clinical manifestations, especially 
those that have experienced organ failures and lungs pneumonia 
pneumonia. It is also of critical importance that once exposed to 
SARS-CoV-2 infection, patients have rigorously been diagnosed of 
neurological and psychiatric disorders over following subsequent 
six months.
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